title: Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice.
abstract: Schistosoma japonicum paramyosin, a 97 kDa myofibrillar protein, is a recognized vaccine candidate against schistosomiasis. To improve its expression and to identify protective epitopic regions on paramyosin, the published Chinese Schistosoma japonicum paramyosin cDNA sequence was redesigned using Pichia codon usage and divided into four overlapping fragments (fragments 1, 2, 3, 4) of 747, 651, 669 and 678 bp, respectively. These gene fragments were synthesized and expressed in Pichia pastoris (fragments 2 and 3) or E. coli (fragments 1 and 4). The recombinant proteins were produced at high level and purified using a two-step process involving Ni-NTA affinity chromatography and gel filtration. BALB/c mice were immunized subcutaneously three times at 2-week-intervals with the purified proteins formulated in adjuvant Quil A. The protein fragments were highly immunogenic, inducing high, though variable, ELISA antibody titres, and each was shown to resemble native paramyosin in terms of its recognition by the anti-fragment antibodies in Western blotting. The immunized mice were subjected to cercarial challenge 2 weeks after the final injection and promising protective efficacy in terms of significant reductions in worm burdens, worm-pair numbers and liver eggs in the vaccinated mice resulted. There was no apparent correlation between the antibody titres generated and protective efficacy, as all fragments produced effective but similar levels of protection.
authors.affiliation: Department of Etiologic Biology, Second Military Medical University, Shanghai, China.
authors.forename: D M
authors.initials: DM
authors.lastname: Zhang
authors.forename: W Q
authors.initials: WQ
authors.lastname: Pan
authors.forename: L
authors.initials: L
authors.lastname: Qian
authors.forename: M
authors.initials: M
authors.lastname: Duke
authors.forename: L H
authors.initials: LH
authors.lastname: Shen
authors.forename: D P
authors.initials: DP
authors.lastname: McManus
mesh_terms: D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D004926:Escherichia coli / Q000235:genetics; D008099:Liver / Q000469:parasitology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010270:Parasite Egg Count; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D010843:Pichia / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D012549:Schistosoma japonicum / Q000235:genetics / Q000276:immunology*; D012554:Schistosomiasis japonica / Q000276:immunology* / Q000517:prevention & control; D014335:Tropomyosin / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D000909:Antibodies, Helminth; D000939:Epitopes; D010446:Peptide Fragments; D011994:Recombinant Proteins; D014335:Tropomyosin; D014614:Vaccines, Synthetic